Effect of immunosuppressants on OKT3 associated T cell activation: Clinical implications
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 32 (3) , 362-367
- https://doi.org/10.1038/ki.1987.218
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTIONTransplantation, 1984
- A REAPPRAISAL OF THE EFFECTS OF MONOCLONAL ANTIBODIES DIRECTED AT T CELL DIFFERENTIATION ANTIGENSTransplantation, 1984
- Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.Journal of Clinical Investigation, 1984
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH MONOCLONAL ANTI-T12 ANTIBODY1,2Transplantation, 1983
- REVERSAL OF TRANSPLANT REJECTION BY MONOCLONAL ANTIBLAST ANTIBODYThe Lancet, 1983
- Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.The Journal of Experimental Medicine, 1983
- Interleukin 2: Biology and biochemistryJournal of Clinical Immunology, 1983
- CHANGES IN HUMAN NATURAL KILLER ACTIVITY EARLY AND LATE AFTER RENAL TRANSPLANTATION USING CONVENTIONAL IMMUNOSUPPRESSIONTransplantation, 1982
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODYTransplantation, 1981